Two additional targets, the growth factor transcriptional repressor GFI1 gene (target number 8) and the nuclear receptor NR2E1 gene (target number 40), were inspected to evaluate the level of methylation in early-stage breast carcinomas. Here, NR2E1 is linked to breast carcinoma.